• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-MAP2K3

MAP2K3 Polyclonal Antibody for WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, ELISA

Conjugaison

Non conjugué

Publications(9)

N° de cat : 13898-1-AP

Synonymes

MEK3, MAPKK3, MAPKK 3, MAPK/ERK kinase 3, MAP kinase kinase 3



Applications testées

Résultats positifs en WBcellules A431, cellules A549, cellules THP-1, tissu de muscle squelettique de rat, tissu de muscle squelettique de souris

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:4000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

13898-1-AP cible MAP2K3 dans les applications de WB, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéerat, Humain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène MAP2K3 Protéine recombinante Ag4861
Nom complet mitogen-activated protein kinase kinase 3
Masse moléculaire calculée 347 aa, 39 kDa
Poids moléculaire observé 36-40 kDa
Numéro d’acquisition GenBankBC032478
Symbole du gène MAP2K3
Identification du gène (NCBI) 5606
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

MAP2K3, also named MKK3, is a member of the dual specificity kinase group and serves as a specific activator of p38 MAPK with MKK6. MKK3 can be phosphorylated by cytokines and environmental stress at sites Ser189 and Thr193 by MKKK proteins (MEKK 1-4). MKK3 plays a key role in cell differentiation, motility, division, and death. It has been reported that MKK3 targeting may represent an effective and potentially safe therapeutic strategy to selectively kill cancer cells in colorectal cancer patients. (PMID: 31695024, 30770795, 26805700, 8622669)

Protocole

Product Specific Protocols
WB protocol for MAP2K3 antibody 13898-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Biomed Pharmacother

Identification of MAP Kinase Kinase 3 as a protein target of myricetin in non-small cell lung cancer cells

Authors - Ling Gu
  • KD Validated
humanWB

Cell Mol Life Sci

HERC2 deficiency activates C-RAF/MKK3/p38 signalling pathway altering the cellular response to oxidative stress

Authors - Joan Sala-Gaston
mouseWB

Food Funct

L-Theanine mediates the p38MAPK signaling pathway to alleviate heat-induced oxidative stress and inflammation in mice.

Authors - Kehong Liu
humanWB

Sci Rep

The ubiquitin ligase HERC1 regulates cell migration via RAF-dependent regulation of MKK3/p38 signaling.

Authors - Leonardo Pedrazza
  • KD Validated
mouseWB

Mol Immunol

Spiroplasma eriocheiris induces mouse 3T6-Swiss albino cell apoptosis that associated with the infection mechanism.

Authors - Libo Hou
humanWB

PLoS One

Proteomic Analysis of eIF5B Silencing-Modulated Proteostasis.

Authors - Xu Jiang
{{ptg:RelatedPrimaryAntibodies}}